PRAXIS PRECISION MEDICINES, INC. Earnings Per Share, Basic and Diluted
PRAXIS PRECISION MEDICINES, INC. (PRAX) reported Earnings Per Share, Basic and Diluted of -$0.71 per share for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-11.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-05-11
- PRAXIS PRECISION MEDICINES, INC. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.71.
- PRAXIS PRECISION MEDICINES, INC. earnings per share, basic and diluted for the quarter ending 2020-12-31 was -$0.86.
- PRAXIS PRECISION MEDICINES, INC. earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$12.10.
- PRAXIS PRECISION MEDICINES, INC. earnings per share, basic and diluted for the quarter ending 2020-03-31 was -$6.08.
- PRAXIS PRECISION MEDICINES, INC. earnings per share, basic and diluted for fiscal 2020 was -$7.86.
- PRAXIS PRECISION MEDICINES, INC. earnings per share, basic and diluted for fiscal 2019 was -$26.60.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2021-03-31 | -$0.71 10-Q · filed 2021-05-11 | -$1.56 derived: net income ÷ weighted average shares · filed 2022-02-28 | -$3.13 derived: net income ÷ weighted average shares · filed 2022-02-28 | |
| 2020-12-31 | -$0.86 derived: net income ÷ weighted average shares · filed 2022-02-28 | -$2.88 derived: net income ÷ weighted average shares · filed 2022-02-28 | -$7.86 10-K · filed 2021-03-17 | |
| 2020-09-30 | -$12.10 10-Q · filed 2020-11-23 | -$26.53 10-Q · filed 2020-11-23 | ||
| 2020-03-31 | -$6.08 10-Q · filed 2021-05-11 | -$11.73 derived: net income ÷ weighted average shares · filed 2021-05-11 | -$19.29 derived: net income ÷ weighted average shares · filed 2021-05-11 | |
| 2019-12-31 | -$5.65 derived: net income ÷ weighted average shares · filed 2021-03-17 | -$13.23 derived: net income ÷ weighted average shares · filed 2021-03-17 | -$26.60 10-K · filed 2021-03-17 | |
| 2019-09-30 | -$7.61 10-Q · filed 2020-11-23 | -$21.02 10-Q · filed 2020-11-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |